Ceva Animal Health Plants Its Flag in the US Companion Animal Market

A new senior vice-president and a relocated global executive signal that Ceva sees the world's biggest pet care market as its next growth engine

Ceva Animal Health is making it official: the companion animal market is now a named strategic focus for the company, and the US is where that focus is landing first. Ceva has named Laura Correro, formerly head of pet therapeutics at Boehringer Ingelheim, as its new senior vice-president of companion animals, and it has relocated Jean-Marcel Ciet, the company's executive vice-president for global companion animals, from overseas to Bridgewater, New Jersey, the operational base of Ceva's US commercial subsidiary.

Two Leadership Moves, One Market

Correro arrives with commercial and strategic experience from her time leading pet therapeutics at Boehringer Ingelheim, and she steps into a role built specifically around Ceva's companion animal ambitions in the US. Ciet's move is arguably the bigger signal. Relocating a global executive vice-president out of a company's international base and onto US soil is not a routine reorg, it is a statement about where leadership believes the next phase of growth has to be run from.

Ciet framed the pairing as a deliberate bet on proximity to the market. He said the US stands as the world's leading pet care market, and that anchoring senior leadership there reflects how seriously the company takes the opportunity.

Why Ceva Is Betting on Local Leadership

Ceva's stated logic is straightforward: leadership based in the US should be able to track market dynamics more closely, move faster on execution, and build stronger relationships with the customers and partners who actually operate in that market. That is a familiar playbook in animal health, where companies headquartered in Europe have historically run their US companion animal business at arm's length from a corporate base overseas. Ceva's move suggests it no longer sees that distance as workable in a market this competitive.

Sebastien Huron, Ceva's deputy chief executive, described the companion animal segment as a key area of development for the company, with the United States playing a central role in that plan. He said the leadership changes reflect an intention to build the company's capabilities over time, one step at a time.

What It Signals for the Rest of the Industry

Leadership relocations like this one are usually early indicators of where budget, headcount, and partnership activity follow next. A newly appointed senior vice-president typically arrives with a mandate to build out a team, expand a product portfolio, and strike new commercial relationships, and a relocated global executive typically arrives with the authority to approve those moves quickly rather than routing them through an overseas parent company. For veterinary professionals, distributors, and media partners in the US companion animal space, Ceva's announcement is worth reading as an opening bid rather than a finished plan. The company is telling the market it intends to be a more visible, more locally engaged player in US companion animal health, and the next round of hires, product launches, and partnerships will show how far that intention goes.

Editorial note: insert the two required internal links here before publish, one to the Vet Candy industry news or animal health business hub page and one to a related article on pharma or animal health leadership moves, per the site's two-link rule.

Reporting drawn from original coverage by Chris Simpson on Ceva Animal Health's companion animal leadership announcement, published September 16, 2026.